{"id":"dummy-infusion","safety":{"commonSideEffects":[{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Vomiting"},{"rate":null,"effect":"Headache"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"The exact mechanism of action of dummy infusion is unknown, but it is thought to work by causing a placebo effect in patients. This can lead to improvements in symptoms and quality of life. However, the effects of dummy infusion are short-lived and do not provide any actual therapeutic benefit.","oneSentence":"Dummy infusion is a treatment that involves the administration of a dummy substance to mimic the effects of a real infusion.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:10:22.159Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of symptoms in patients with a known or suspected diagnosis of a serious medical condition"}]},"trialDetails":[{"nctId":"NCT06742190","phase":"PHASE3","title":"A Study to Assess the Efficacy and Safety of Empasiprubart Versus IVIg in Adults With Multifocal Motor Neuropathy","status":"RECRUITING","sponsor":"argenx","startDate":"2024-12-18","conditions":"Multifocal Motor Neuropathy (MMN), MMN","enrollment":115},{"nctId":"NCT06059846","phase":"PHASE3","title":"A Study of Oral Tebipenem Pivoxil Hydrobromide (TBP-PI-HBr) Compared to Intravenous Imipenem-cilastatin in Participants With Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)","status":"COMPLETED","sponsor":"Spero Therapeutics","startDate":"2023-12-21","conditions":"Urinary Tract Infection, Acute Pyelonephritis","enrollment":1690},{"nctId":"NCT06920004","phase":"PHASE3","title":"A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP","status":"RECRUITING","sponsor":"argenx","startDate":"2025-08-22","conditions":"Chronic Inflammatory Demyelinating Polyneuropathy, CIDP, CIDP - Chronic Inflammatory Demyelinating Polyneuropathy","enrollment":218},{"nctId":"NCT07453004","phase":"PHASE2","title":"A Study to Evaluate the Efficacy,Safety,Tolerability,Pharmacokinetics,and Immunogenicty of Plonmarlimab in Subjects With Acute Gouty Arthritis","status":"NOT_YET_RECRUITING","sponsor":"TJ Biopharma Co., Ltd.","startDate":"2026-04-01","conditions":"Acute Gouty Arthritis","enrollment":170},{"nctId":"NCT07281014","phase":"PHASE4","title":"Unmitigated Aldosterone Signaling During Standard Clinical MRA Dosing","status":"RECRUITING","sponsor":"Yale University","startDate":"2026-01-27","conditions":"Heart Failure","enrollment":20},{"nctId":"NCT03295383","phase":"PHASE3","title":"Randomized Clinical Trial Comparing the Safety and Efficacy of Rituximab Versus Oral Cyclophosphamide in Severe Forms of Mucous Membrane Pemphigoid","status":"RECRUITING","sponsor":"University Hospital, Rouen","startDate":"2019-07-11","conditions":"Severe Forms of Mucous Membrane Pemphigoid","enrollment":130},{"nctId":"NCT05123703","phase":"PHASE3","title":"A Study to Evaluate Safety and Efficacy of Ocrelizumab in Comparison With Fingolimod in Children and Adolescents With Relapsing-Remitting Multiple Sclerosis (RRMS)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hoffmann-La Roche","startDate":"2022-05-19","conditions":"Relapsing-Remitting Multiple Sclerosis","enrollment":188},{"nctId":"NCT05324358","phase":"PHASE3","title":"Ketorolac Applied by Continuous IV Infusion for Treatment of Moderately Severe Postoperative Pain Following Bunionectomy","status":"COMPLETED","sponsor":"Neumentum, Inc.","startDate":"2022-12-14","conditions":"Pain, Postoperative","enrollment":341},{"nctId":"NCT07111806","phase":"PHASE3","title":"Intravenous Tirofiban After Delayed Thrombolysis in Stroke","status":"NOT_YET_RECRUITING","sponsor":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","startDate":"2025-12-01","conditions":"Acute Ischemic Stroke","enrollment":852},{"nctId":"NCT06996730","phase":"PHASE2, PHASE3","title":"A Study of Donanemab, RG6289, or the Combination of Donanemab and RG6289 in Presenilin 1 (PSEN1) E280A Mutation Carriers for the Treatment of Autosomal-Dominant Alzheimer's Disease","status":"NOT_YET_RECRUITING","sponsor":"Banner Health","startDate":"2026-01-15","conditions":"Autosomal Dominant Alzheimers Disease, Early Onset Alzheimer Disease, Alzheimers Disease","enrollment":240},{"nctId":"NCT05518877","phase":"PHASE4","title":"Low Dose Ketamine Infusion for Analgesia in the Emergency Department to Reduce Side Effects","status":"COMPLETED","sponsor":"Summa Health System","startDate":"2022-12-07","conditions":"Pain, Acute, Dissociation","enrollment":48},{"nctId":"NCT04006210","phase":"PHASE3","title":"Efficacy, Safety and Tolerability Study of ND0612 vs. Oral Immediate Release Levodopa/Carbidopa (IR-LD/CD) in Subjects With Parkinson's Disease Experiencing Motor Fluctuations","status":"ACTIVE_NOT_RECRUITING","sponsor":"NeuroDerm Ltd.","startDate":"2019-09-30","conditions":"Parkinson's Disease","enrollment":381},{"nctId":"NCT03808259","phase":"PHASE1","title":"A Study to Investigate the Different Modes of (S) Ketamine Administration in Healthy Participants","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2018-12-20","conditions":"Healthy","enrollment":96},{"nctId":"NCT02682225","phase":"PHASE1","title":"Crossover Study to Evaluate the Abuse Potential of Intranasal Esketamine Compared to Racemic Intravenous Ketamine in Nondependent, Recreational Drug Users","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2016-03-25","conditions":"Drug Abuse","enrollment":55},{"nctId":"NCT00630552","phase":"PHASE1, PHASE2","title":"QUILT-2.019: A Study of AMG 655 or AMG 479 in Combination With Gemcitabine for Treatment of Metastatic Pancreatic Cancer","status":"COMPLETED","sponsor":"NantCell, Inc.","startDate":"2007-06","conditions":"Adenocarcinoma of the Pancreas, Metastatic Pancreatic Cancer, Pancreatic Cancer","enrollment":138},{"nctId":"NCT02112656","phase":"PHASE3","title":"Study of ThermoDox With Standardized Radiofrequency Ablation (RFA) for Treatment of Hepatocellular Carcinoma (HCC)","status":"COMPLETED","sponsor":"Imunon","startDate":"2014-06","conditions":"Hepatocellular Carcinoma","enrollment":554},{"nctId":"NCT06319846","phase":"PHASE3","title":"Tirofiban for Patients With intraCranial Artery Stenosis and High-risk Acute Non-disabling Cerebrovascular Events(CHANCE-4）","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2024-07-11","conditions":"Ischemic Stroke, Acute, TIA, Symptomatic Intracranial Artery Stenosis","enrollment":4674},{"nctId":"NCT00617981","phase":"PHASE3","title":"Phase 3 Study of ThermoDox With Radiofrequency Ablation (RFA) in Treatment of Hepatocellular Carcinoma (HCC)","status":"COMPLETED","sponsor":"Imunon","startDate":"2008-05","conditions":"Hepatocellular Carcinoma","enrollment":701},{"nctId":"NCT00800215","phase":"PHASE2","title":"A Trial to Investigate the Safety, Tolerability and Pharmacokinetics of Intravenous SPM 927","status":"COMPLETED","sponsor":"UCB Pharma","startDate":"2004-03-04","conditions":"Epilepsy","enrollment":60},{"nctId":"NCT01412333","phase":"PHASE3","title":"A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2011-09-20","conditions":"Relapsing Multiple Sclerosis","enrollment":835},{"nctId":"NCT01247324","phase":"PHASE3","title":"A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2011-08-31","conditions":"Relapsing Multiple Sclerosis","enrollment":821},{"nctId":"NCT03197194","phase":"PHASE3","title":"A Phase III Randomized, Blind, Double Dummy, Multicenter Study Assessing the Efficacy and Safety of IV THrombolysis (Alteplase) in Patients With acutE Central retInal Artery Occlusion","status":"COMPLETED","sponsor":"Nantes University Hospital","startDate":"2018-06-08","conditions":"Central Retinal Artery Occlusion","enrollment":70},{"nctId":"NCT03551210","phase":"PHASE3","title":"Efficacy and Safety of Nemonoxacin vs Levofloxacin in Adult Patients With Community-Acquired Pneumonia","status":"COMPLETED","sponsor":"R-Pharm","startDate":"2016-05-04","conditions":"Pneumonia, Bacterial","enrollment":342},{"nctId":"NCT05204368","phase":"PHASE3","title":"Evaluation of the Efficacy and Safety of Intravenous Imipenem/Cilastatin/XNW4107 in Comparison With Meropenem in Hospitalized Adults With cUTI Including AP (EudraCT no. 2022-000061-40)","status":"UNKNOWN","sponsor":"Evopoint Biosciences Inc.","startDate":"2023-03-30","conditions":"Complicated Urinary Tract Infection Including Acute Pyelonephritis","enrollment":780},{"nctId":"NCT04380142","phase":"PHASE3","title":"Study Comparing Continuous Subcutaneous Infusion Of ABBV-951 With Oral Carbidopa/Levodopa Tablets For Treatment Of Motor Fluctuations In Adult Participants With Advanced Parkinson's Disease","status":"COMPLETED","sponsor":"AbbVie","startDate":"2020-10-19","conditions":"Parkinson's Disease (PD)","enrollment":174},{"nctId":"NCT05451095","phase":"PHASE1","title":"A Study in Healthy Men to Test Whether BI 474121 Can Reverse the Memory Problems Caused by Ketamine","status":"WITHDRAWN","sponsor":"Boehringer Ingelheim","startDate":"2022-11-07","conditions":"Healthy","enrollment":""},{"nctId":"NCT03788967","phase":"PHASE3","title":"Study to Assess the Efficacy, Safety and Pharmacokinetics of Orally Administered Tebipenem Pivoxil Hydrobromide (SPR994) Compared to Intravenous Ertapenem in Participants With Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)","status":"COMPLETED","sponsor":"Spero Therapeutics","startDate":"2019-06-03","conditions":"Complicated Urinary Tract Infection, Acute Pyelonephritis","enrollment":1372},{"nctId":"NCT04165122","phase":"PHASE2","title":"Monoclonal Antibody Therapy Against Chronic Herpes Simplex Virus 2 Infection","status":"COMPLETED","sponsor":"Heidelberg ImmunoTherapeutics GmbH","startDate":"2019-11-15","conditions":"Herpes Genitalis","enrollment":122},{"nctId":"NCT01844856","phase":"PHASE3","title":"Efficacy and Safety Study of Eravacycline Compared With Ertapenem in Complicated Intra-abdominal Infections","status":"COMPLETED","sponsor":"Tetraphase Pharmaceuticals, Inc","startDate":"2013-08","conditions":"Complicated Intra-abdominal Infections","enrollment":541},{"nctId":"NCT01265784","phase":"PHASE2","title":"Study to Compare TP-434 and Ertapenem in Community-acquired Complicated Intra-abdominal Infections","status":"COMPLETED","sponsor":"Tetraphase Pharmaceuticals, Inc","startDate":"2011-01","conditions":"Complicated Intra-abdominal Infection","enrollment":143},{"nctId":"NCT02136069","phase":"PHASE3","title":"A Study Comparing the Efficacy and Safety of Etrolizumab to Infliximab in Participants With Moderate to Severe Ulcerative Colitis Who Are Naïve to Tumor Necrosis Factor (TNF) Inhibitors","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2014-12-24","conditions":"Ulcerative Colitis","enrollment":397},{"nctId":"NCT02964338","phase":"PHASE3","title":"A Study Comparing the Efficacy and Safety of Fremanezumab (TEV-48125) for the Prevention of Chronic Cluster Headache (CCH)","status":"TERMINATED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2017-01-17","conditions":"Chronic Cluster Headache","enrollment":259},{"nctId":"NCT03107052","phase":"PHASE3","title":"A Study to Explore the Long-Term Safety and Efficacy of Fremanezumab (TEV-48125) for the Prevention of Cluster Headache","status":"TERMINATED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2017-04-27","conditions":"Cluster Headache","enrollment":275},{"nctId":"NCT02945046","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of TEV-48125 (Fremanezumab) for the Prevention of Episodic Cluster Headache (ECH)","status":"TERMINATED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2017-01-19","conditions":"Episodic Cluster Headache","enrollment":169},{"nctId":"NCT05060419","phase":"PHASE2","title":"Meropenem-FL058 Phase 2 Study in the Treatment of Complicated Urinary Tract Infections","status":"UNKNOWN","sponsor":"Qilu Pharmaceutical Co., Ltd.","startDate":"2021-10-08","conditions":"Complicated Urinary Tract Infection, Acute Pyelonephritis","enrollment":150},{"nctId":"NCT01364389","phase":"PHASE2","title":"A 3-arm Proof of Concept Study of AIN457, ACZ885 or Corticosteroids in Patients With Polymyalgia Rheumatica","status":"TERMINATED","sponsor":"Novartis Pharmaceuticals","startDate":"2011-02-14","conditions":"Polymyalgia Rheumatica, Inflammatory Diseases","enrollment":16},{"nctId":"NCT03823391","phase":"PHASE2","title":"A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of ABBV-3373 in Participants With Moderate to Severe Rheumatoid Arthritis (RA)","status":"COMPLETED","sponsor":"AbbVie","startDate":"2019-03-27","conditions":"Rheumatoid Arthritis (RA)","enrollment":48},{"nctId":"NCT02685618","phase":"PHASE2","title":"Endothelial Dysfunction in Resuscitated Cardiac Arrest","status":"COMPLETED","sponsor":"Pär Johansson","startDate":"2016-02","conditions":"Cardiac Arrest","enrollment":50},{"nctId":"NCT03965533","phase":"PHASE1","title":"Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GSK2831781 After an Intravenous (IV) Dose in Healthy Japanese and Caucasian Subjects, and a Subcutaneous (SC) Dose in Healthy Caucasian Subjects","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2019-06-10","conditions":"Healthy Volunteers","enrollment":36},{"nctId":"NCT02383589","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Rituximab Versus Mycophenolate Mofetil (MMF) in Participants With Pemphigus Vulgaris (PV)","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2015-05-26","conditions":"Pemphigus Vulgaris","enrollment":135},{"nctId":"NCT03403712","phase":"PHASE3","title":"A Study to Assess the Safety and the Efficacy of IV Fosnetupitant/Palonosetron (260 mg/0.25 mg) Combination Compared to Oral Netupitant/Palonosetron (300 mg/0.5 mg) Combination for the Prevention of CINV in AC Chemotherapy in Women With Breast Cancer","status":"COMPLETED","sponsor":"Helsinn Healthcare SA","startDate":"2018-03-16","conditions":"Chemotherapy-induced Nausea and Vomiting","enrollment":404},{"nctId":"NCT02497469","phase":"PHASE3","title":"An Efficacy and Safety Study of Vedolizumab Intravenous (IV) Compared to Adalimumab Subcutaneous (SC) in Participants With Ulcerative Colitis","status":"COMPLETED","sponsor":"Takeda","startDate":"2015-06-29","conditions":"Colitis, Ulcerative","enrollment":771},{"nctId":"NCT00444158","phase":"PHASE1","title":"Double-Blind, Double-Dummy, 2-Period Crossover of a 20-Minute Versus a 4-hour IV of MOA-728 in Stable Methadone Subjects","status":"COMPLETED","sponsor":"Bausch Health Americas, Inc.","startDate":"2007-03","conditions":"Constipation","enrollment":24},{"nctId":"NCT03251482","phase":"PHASE2","title":"A Study to Evaluate the Safety and Efficacy of Intravenous JNJ-64179375 Versus Oral Apixaban in Participants Undergoing Elective Total Knee Replacement Surgery","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2017-11-13","conditions":"VTE Prophylaxis With Anticoagulation After Total Knee Replacement Surgery","enrollment":308},{"nctId":"NCT03533179","phase":"PHASE4","title":"Glucagon's Cardiovascular Effects With and Without Beta-blocker-induced Cardioinhibition","status":"COMPLETED","sponsor":"University Hospital Bispebjerg and Frederiksberg","startDate":"2018-06-01","conditions":"Drug Overdose, Overdose of Beta-adrenergic Blocking Drug","enrollment":10},{"nctId":"NCT03477422","phase":"PHASE3","title":"CSE-1034 (Ceftriaxone+ Sulbactam+ EDTA) Compared to Meropenem in Complicated Urinary Tract Infections (cUTIs) Caused by ESBL Producing Gram Negative Bacteria","status":"COMPLETED","sponsor":"Venus Remedies Limited","startDate":"2014-01-11","conditions":"Urinary Tract Infection Complicated, Acute Pyelonephritis","enrollment":230},{"nctId":"NCT01231620","phase":"PHASE3","title":"A Study of Intravenous Zanamivir Versus Oral Oseltamivir in Adults and Adolescents Hospitalized With Influenza","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2011-01-15","conditions":"Influenza, Human","enrollment":626},{"nctId":"NCT03609775","phase":"PHASE1","title":"A Study to Investigate the Drug-drug Interactions Between ACT-541468 and Ethanol in Healthy Subjects","status":"COMPLETED","sponsor":"Idorsia Pharmaceuticals Ltd.","startDate":"2018-08-28","conditions":"Healthy","enrollment":22},{"nctId":"NCT01922011","phase":"PHASE3","title":"Safety and Efficacy Study of Daptomycin Compared to Active Comparator in Pediatric Participants With Acute Hematogenous Osteomyelitis (AHO) (MK-3009-006)","status":"COMPLETED","sponsor":"Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)","startDate":"2013-09-13","conditions":"Acute Hematogenous Osteomyelitis","enrollment":149},{"nctId":"NCT03554304","phase":"PHASE1","title":"Evaluate the Effect of WCK 5222 on the QT/QTc Interval in Healthy Volunteers","status":"COMPLETED","sponsor":"Wockhardt","startDate":"2017-02-09","conditions":"QT/QTc Interval in Healthy Volunteers","enrollment":60},{"nctId":"NCT02221531","phase":"PHASE4","title":"Carbetocin Trial: Carbetocin Appropriate Rate Better Equilibrium Between Tonus (TOnus) and CIrculatioN","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2014-08","conditions":"Complications; Cesarean Section, Anesthesia; Reaction","enrollment":140},{"nctId":"NCT01599806","phase":"PHASE3","title":"Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections)","status":"COMPLETED","sponsor":"Pfizer","startDate":"2012-10","conditions":"Complicated Urinary Tract Infection (cUTI) Including Acute Pyelonephritis","enrollment":641},{"nctId":"NCT01726023","phase":"PHASE3","title":"Compare Ceftazidime-Avibactam + Metronidazole vs Meropenem for Hospitalized Adults With Complicated Intra-Abd Infections","status":"COMPLETED","sponsor":"Pfizer","startDate":"2013-01","conditions":"Complicated Intra-abdominal Infection","enrollment":486},{"nctId":"NCT01595438","phase":"PHASE3","title":"Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections)","status":"COMPLETED","sponsor":"Pfizer","startDate":"2012-10","conditions":"Complicated Urinary Tract Infection (cUTI) Including Acute Pyelonephritis","enrollment":598},{"nctId":"NCT02137525","phase":"PHASE2","title":"Study to Explore Effectiveness of Sublingual Fentanyl Spray in Emergency Department Patients With Acute Pain","status":"WITHDRAWN","sponsor":"INSYS Therapeutics Inc","startDate":"","conditions":"Acute Pain","enrollment":""},{"nctId":"NCT01768572","phase":"PHASE3","title":"To Evaluate The Safety of SAR153191 (REGN88) and Tocilizumab Added to Other RA Drugs in Patients With RA Who Are Not Responding to or Intolerant of Anti-TNF Therapy (SARIL-RA-ASCERTAIN)","status":"COMPLETED","sponsor":"Sanofi","startDate":"2013-03","conditions":"Rheumatoid Arthritis","enrollment":202},{"nctId":"NCT01928433","phase":"PHASE2","title":"Finafloxacin for the Treatment of cUTI and/or Acute Pyelonephritis","status":"COMPLETED","sponsor":"MerLion Pharmaceuticals GmbH","startDate":"2012-12","conditions":"Urinary Tract Infections, Acute Pyelonephritis","enrollment":225},{"nctId":"NCT02204852","phase":"PHASE2","title":"Co-administration of Iloprost and Eptifibatide in Septic Shock Patients","status":"COMPLETED","sponsor":"Sisse R. Ostrowski, MD PhD DMSc","startDate":"2014-09","conditions":"Septic Shock","enrollment":18},{"nctId":"NCT02924454","phase":"PHASE4","title":"Effects of Lipid Emulsion on the Pharmacokinetic and Pharmacodynamic Properties of Metoprolol.","status":"COMPLETED","sponsor":"Mikkel Bring Christensen","startDate":"2016-09","conditions":"Drug Overdose, Overdose of Beta-adrenergic Blocking Drug, Blood Pressure","enrollment":10},{"nctId":"NCT02508753","phase":"PHASE1","title":"Safety Study Designed to Study the Effects of Two Different Doses of CXA-101/Tazobactam, a Low Dose and a High Dose, on the QT/QTc Intervals in Healthy Subjects","status":"COMPLETED","sponsor":"Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)","startDate":"2010-06","conditions":"Healthy","enrollment":52},{"nctId":"NCT01244139","phase":"PHASE1","title":"Safety Study of BIIB033 in Subjects With Multiple Sclerosis","status":"COMPLETED","sponsor":"Biogen","startDate":"2010-10","conditions":"Relapsing-Remitting Multiple Sclerosis, Multiple Sclerosis","enrollment":47},{"nctId":"NCT02165332","phase":"PHASE1","title":"A Two-part, Single-dose, Randomized Study to Evaluate the Safety of Supra-therapeutic Doses of RO7033877 and to Investigate the Effect of RO7033877 on the QTc Interval","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2014-07","conditions":"Healthy Volunteer","enrollment":64},{"nctId":"NCT02693210","phase":"PHASE2","title":"A Study to Evaluate the Efficacy and Safety of Mabthera Alone and in Combination With Either Cyclophosphamide or Methotrexate in Patients With Rheumatoid Arthritis","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2001-02","conditions":"Rheumatoid Arthritis","enrollment":161},{"nctId":"NCT00813605","phase":"PHASE2","title":"QUILT-2.018: Safety & Efficacy of FOLFIRI With AMG 479 or AMG 655 vs FOLFIRI Alone in KRAS-mutant Metastatic Colorectal Carcinoma","status":"COMPLETED","sponsor":"NantCell, Inc.","startDate":"2009-03","conditions":"Metastatic Colorectal Cancer","enrollment":155},{"nctId":"NCT01527968","phase":"NA","title":"Epsilon Aminocaproic Acid Vs. Tranexamic Acid Vs. Placebo for Prevention of Blood Loss in Total Knee Arthroplasty","status":"UNKNOWN","sponsor":"Heekin Orthopedic Research Institute","startDate":"2012-04","conditions":"Osteoarthritis","enrollment":54},{"nctId":"NCT01076764","phase":"PHASE3","title":"Effect of Otamixaban Versus Unfractionated Heparin + Eptifibatide in Patients With Unstable Angina/Non ST Elevation Myocardial Infarction Undergoing Early Invasive Strategy","status":"COMPLETED","sponsor":"Sanofi","startDate":"2010-04","conditions":"Acute Coronary Syndrome","enrollment":13220},{"nctId":"NCT00345618","phase":"PHASE3","title":"Clinical Study Assessing Idrabiotaparinux Sodium Injections Once-weekly in Pulmonary Embolism Therapeutic Approach","status":"COMPLETED","sponsor":"Sanofi","startDate":"2006-06","conditions":"Embolism, Thrombosis","enrollment":3202},{"nctId":"NCT00797108","phase":"PHASE2","title":"A Study Of Intravenous Sulopenem And Oral PF-03709270 In Community Acquired Pneumonia That Requires Hospitalization","status":"COMPLETED","sponsor":"Pfizer","startDate":"2009-01","conditions":"Pneumonia, Bacterial","enrollment":35},{"nctId":"NCT00906204","phase":"PHASE2","title":"Safety Trial of Single Versus Multiple Dose Thymoglobulin Induction in Kidney Transplantation","status":"COMPLETED","sponsor":"Wright State University","startDate":"2010-03","conditions":"End-Stage Renal Disease, Kidney Failure","enrollment":99},{"nctId":"NCT00559585","phase":"PHASE3","title":"Methotrexate-Inadequate Response Study","status":"COMPLETED","sponsor":"Bristol-Myers Squibb","startDate":"2008-01","conditions":"Rheumatoid Arthritis (RA)","enrollment":2492},{"nctId":"NCT00453999","phase":"PHASE2","title":"Evaluation of Efficacy and Safety of Peramivir in Adults With Acute Serious or Potentially Life-threatening Influenza","status":"COMPLETED","sponsor":"BioCryst Pharmaceuticals","startDate":"2007-07","conditions":"Influenza","enrollment":137},{"nctId":"NCT00357994","phase":"PHASE3","title":"Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects","status":"COMPLETED","sponsor":"AbbVie (prior sponsor, Abbott)","startDate":"2009-01","conditions":"Advanced Parkinson's Disease","enrollment":36},{"nctId":"NCT00660387","phase":"PHASE3","title":"Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects","status":"COMPLETED","sponsor":"AbbVie (prior sponsor, Abbott)","startDate":"2009-12","conditions":"Advanced Parkinson's Disease","enrollment":35},{"nctId":"NCT00492726","phase":"PHASE3","title":"Therapy of Complicated Intra-Abdominal Infections With Moxifloxacin or Ertapenem","status":"COMPLETED","sponsor":"Bayer","startDate":"2006-07","conditions":"Infection","enrollment":804},{"nctId":"NCT00625651","phase":"PHASE1, PHASE2","title":"Phase 1b/2 Study of AMG 655 With mFOLFOX6 and Bevacizumab for First-Line Metastatic Colorectal Cancer","status":"COMPLETED","sponsor":"Amgen","startDate":"2007-10","conditions":"Metastatic Colorectal Cancer, Colon Cancer, Colorectal Cancer","enrollment":202},{"nctId":"NCT01983514","phase":"PHASE1","title":"Effects of Intranasal Administration of a Single Dose of Oxytocin Using a Novel Device in Healthy Adults","status":"COMPLETED","sponsor":"OptiNose AS","startDate":"2013-10","conditions":"Healthy Male Adults","enrollment":19},{"nctId":"NCT01001832","phase":"PHASE2, PHASE3","title":"Efficacy, Pharmacokinetics, Safety, and Immunogenicity Study of Abatacept Administered Subcutaneously to Treat Rheumatoid Arthritis in Japanese Patients","status":"COMPLETED","sponsor":"Bristol-Myers Squibb","startDate":"2009-12","conditions":"Rheumatoid Arthritis","enrollment":118},{"nctId":"NCT01780129","phase":"PHASE2","title":"Polydatin Injectable (HW6) for Shock Treatment","status":"UNKNOWN","sponsor":"Neptunus Pharmaceuticals Inc.","startDate":"2013-02","conditions":"Shock, Hemorrhagic, Shock, Traumatic, Shock, Septic","enrollment":240},{"nctId":"NCT00663169","phase":"PHASE2","title":"Efficacy and Safety of a Single Dose of Canakinumab (ACZ885) in Hospitalized Patients With Acute Gout","status":"COMPLETED","sponsor":"Novartis","startDate":"2008-04","conditions":"Arthritis, Gouty","enrollment":6},{"nctId":"NCT00589693","phase":"PHASE3","title":"To Compare Safety and Efficacy of Doripenem Versus Imipenem-Cilastatin in Patients With Ventilator-Associated Pneumonia","status":"TERMINATED","sponsor":"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.","startDate":"2008-04","conditions":"Ventilator-Associated Pneumonia","enrollment":274},{"nctId":"NCT00534313","phase":"PHASE2","title":"Safety and Efficacy of Abatacept Versus Placebo in Participants With Psoriatic Arthritis","status":"TERMINATED","sponsor":"Bristol-Myers Squibb","startDate":"2007-11","conditions":"Psoriatic Arthritis","enrollment":191},{"nctId":"NCT00431444","phase":"PHASE4","title":"Effects of Zoledronic Acid and Raloxifene on Bone Turnover Markers in Postmenopausal Women With Low Bone Mineral Density","status":"COMPLETED","sponsor":"Novartis","startDate":"2007-01","conditions":"Osteoporosis","enrollment":110},{"nctId":"NCT00489424","phase":"PHASE4","title":"Acetaminophen or Fluvastatin Compared to Placebo on the Transient Post-Dose Symptoms (PDS) Following an Intravenous (i.v.) Infusion of a Single Dose of Zoledronic Acid 5mg, in Post-menopausal Women With Low Bone Mass","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2007-06","conditions":"Osteoporosis","enrollment":793},{"nctId":"NCT00262054","phase":"PHASE4","title":"Un-fractionated Heparin Versus Bivalirudin During Percutaneous Coronary Interventions (PCI) (ISAR-REACT-3)","status":"COMPLETED","sponsor":"Deutsches Herzzentrum Muenchen","startDate":"2005-11","conditions":"Coronary Disease, Angina Pectoris","enrollment":4570},{"nctId":"NCT00632242","phase":"PHASE2","title":"ARC1779 Injection in Patients With Von Willebrand Factor-Related Platelet Function Disorders","status":"COMPLETED","sponsor":"Archemix Corp.","startDate":"2008-01","conditions":"Purpura, Thrombotic Thrombocytopenic, Von Willebrand Disease Type-2b","enrollment":28}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":125,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Placebo"],"phase":"phase_3","status":"active","brandName":"Dummy infusion","genericName":"Dummy infusion","companyName":"Imunon","companyId":"imunon","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Dummy infusion is a treatment that involves the administration of a dummy substance to mimic the effects of a real infusion. Used for Treatment of symptoms in patients with a known or suspected diagnosis of a serious medical condition.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}